Great news and updates regarding two articles I recently wrote. One has gone on to publication while the other has moved to being classified as “in press.” The first article, “Pre-Exposure Prophylaxis: An Emerging Clinical Approach to Preventing HIV in High-Risk Adults” has been published in this month’s issue of The Nurse Practitioner: The American Journal of Primary Healthcare. The article explores advances in HIV prevention in those at high risk through the use of the antiretroviral medication Truvada. The abstract appears below.
Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults
Abstract: The HIV antiretroviral drug emtricitabine/tenofovir disoproxil fumarate (Truvada) was recently approved as preexposure prophylaxis (PrEP) therapy for adults at high risk for sexually acquired HIV infection. This article reviews the data supporting the efficacy of PrEP, and provides other relevant data regarding the implementation of PrEP.
In other news, my article, “Assessment and Treatment of Depression in Gay and Bisexual Men in Emergency Settings” has been FULLY accepted for publication in the Advanced Emergency Nursing Journal and will most likely appear in-publication early next year. Browse my publications under the Research tab and download my CV for a full listing of my publication record.



A study appearing today in the New England Journal of Medicine highlights research findings that the antiretroviral drug Truvada is highly effective at preventing HIV infection in men who have sex with men (MSM). Researchers studied the effect of Truvada in a sample of 2,500 MSM in San Francisco, CA and Lima, Peru. While infection rates declined an average of 44%; when participants took the drug precisely as prescribed, its efficacy rose to up to 90%! Adverse effects are low and included nausea, increased creatinine, and weight loss. The finding holds promise that perhaps pre-exposure prophylactic treatment could be the key to greatly reducing infection rates in the population at most risk. Of great concern, however is the cost. In the US, Truvada costs between $12,000-$14,000 annually. In addition, Gilead, the maker of the drug needs to pursue FDA approval for the pre-exposure indication, which could take months.
I am very happy to report that two of my articles were accepted for publication in the Journal of Social Service Research this week. The first, an article that was reworked from a data-driven to a clinical piece is titled, “Using the Internet to Meet Sexual Partners: Research and Practice Implications.” The article, focusing on drug use within sexual relationships initiated in the on-line environment, is co-written by Dr. Sophia Dziegielewski (Professor, School of Social Work, University of Cincinnati) and will appear in a special upcoming GLBT-focused issue of the journal. The second, “Reducing Alcohol Abuse in Gay Men: Clinical Recommendations from Conflicting Research” sheds light on the conflicting studies about alcohol use and abuse in gay men and provides the clinician with recommendations on how to effectively screen gay male clients for alcohol abuse. Both should appear in-print and on-line in late 2010 or early 2011.
Great news! I just received a confirmation E-Mail from the editor of Social Work in Public Health informing me my research article “Requests for Bareback Sex and HIV Serostatus among Men who Have Sex with Men Using Internet Sexual Networking Sites to Initiate Sexual Relationships” has been ACCEPTED for publication! Social Work in Public Health is a crucial journal focusing on all aspects of policy and social and health care considerations in policy-related matters, including its development, formulation, implementation, evaluation, review, and revision. By blending conceptual and practical considerations, Social Work in Public Health enables authors from many disciplines to examine health and social policy issues, concerns, and questions. Dr. Mary Lou Sole partnered with me in the work, providing great assistance in the statistical analyses of my research. Below is the APA Citation and Abstract:

